Upregulation of PD-1 and PDL-1 was seen in CD34+ BM cells from patients with MDS and in T-cells, with further upregulation seen in those previously treated with HMAs [77,78]. This evidence concerns the gene PDCD1 and myelodysplastic syndrome.